沙美特罗替卡松联合孟鲁司特治疗支气管哮喘的临床疗效

SALMETEROL Fluticasone Montelukast Bronchial Asthma Combined Treatment of Clinical Curative Effect

目的:探讨沙美特罗替卡松联合孟鲁司特治疗支气管哮喘的临床疗效。方法:将我院收治的80例支气管哮喘患者随机分为治疗组和对照组各40例,治疗组给予沙美特罗替卡松联合孟鲁司特治疗,对照组仅给予沙美特罗替卡松治疗,比较2组患者的临床疗效。结果:治疗组的总有效率为100%,对照组的总有效率为75%,治疗组的总有效率显著优于对照组,2组比较,差异具有统计学意义(P<0.05)。结论:沙美特罗替卡松联合孟鲁司特治疗支气管哮喘的临床效果显著,能有效改善患者的临床症状和呼吸功能,其用药安全可靠,无明显不良反应,值得临床推广应用。

Objective：To explore SALMETEROL Fluticasone montelukast combined treatment of bronchial asthma clinical curative effect.Methods： Will we treated 80 cases of bronchial asthma patients were randomly divided into treatment group and control group each 40 cases, the treatment group was given SALMETEROL Fluticasone montelukast combined treatment group, only give SALMETEROL Fluticasone treatment, compared between the two groups of patients with clinical curative effect.Results： The treatment group total effective rate was 100%, the control group total effective rate was 75%, total effective rate of the treatment group was superior to control group, two groups of comparisons, a statistically significant difference （P 0.05）. Conclusions： SALMETEROL Fluticasone montelukast bronchial asthma combined treatment of clinical effect is remarkable, and the patients can effectively improve the clinical symptoms and respiratory function, its drug safety and reliable, and no obvious adverse reaction, it is worth clinical application.